The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittler, R. S.
Right arrow Articles by Herndon, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittler, R. S.
Right arrow Articles by Herndon, V.

The Journal of Immunology, Vol 153, Issue 1 84-96, Copyright © 1994 by American Association of Immunologists


ARTICLES

CD45-mediated regulation of extracellular calcium influx in a CD4- transfected human T cell line

RS Mittler, GL Schieven, PM Dubois, K Klussman, MP O'Connell, PA Kiener and V Herndon
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Transfection of a CD4- Jurkat leukemic T cell line with the human wild- type CD4 gene resulted in the constitutive mobilization of calcium by these cells. The altered calcium phenotype was dependent on expression of a completely functional CD4 molecule on the cell surface. Transfectants receiving the vector alone or those in which a mutated CD4 gene lacking a functional Lck binding region failed to generate a constitutive calcium response. In addition, CD4 wild-type transfectants over time lost CD4 expression. These CD4- revertants failed to constitutively mobilize calcium. Treatment of CD4 wild-type transfected cells with either anti-CD45 mAb, EGTA, or PMA rapidly restored the cells to basal levels of intracellular calcium. Analysis of CD45 cross- linking on CD4+ and CD4- normal Jurkat lines demonstrated that CD4 expression was required for CD45-mediated inhibition of TCR induced calcium responses. CD45-mediated inhibition affected the duration of the response rather than its magnitude. These results, taken together with the observations obtained with CD4 transfected Jurkats suggested that influx of extracellular calcium was the predominant reason for the elevated levels of calcium within the cell. In support of this hypothesis, we could find no evidence of phosphorylated phospholipase C gamma 1 or constitutive inositol 1,4,5 trisphosphate generation in the CD4 wild-type transfected cells, yet both were detectable after anti- CD3 mAb-induced activation. Immunokinase assays of Lck and Fyn precipitated from untreated or anti-CD45-treated wild-type transfectants demonstrated that CD45 cross-linking dephosphorylated Lck and reduced its capacity to phosphorylate enolase. In contrast, neither Fyn autophosphorylation nor its activity was affected by CD45 cross- linking.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Yamada, D. Zhu, A. Saxon, and K. Zhang
CD45 Controls Interleukin-4-mediated IgE Class Switch Recombination in Human B Cells through Its Function as a Janus Kinase Phosphatase
J. Biol. Chem., August 2, 2002; 277(32): 28830 - 28835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Barbeau, G. A. Robichaud, J.-F. Fortin, and M. J. Tremblay
Negative Regulation of the NFAT1 Factor by CD45: Implication in HIV-1 Long Terminal Repeat Activation
J. Immunol., September 1, 2001; 167(5): 2700 - 2713.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Majeti, A. M. Bilwes, J. P. Noel, T. Hunter, and A. Weiss
Dimerization-Induced Inhibition of Receptor Protein Tyrosine Phosphatase Function Through an Inhibitory Wedge
Science, January 2, 1998; 279(5347): 88 - 91.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.